Synthesis and cytotoxicity evaluation of 2-Phenyl-1H-benzo[de]isoquinoline-1,3(2H)-dione derivatives as apoptosis inducers with probable anticancer effects
DOI:
https://doi.org/10.7439/ijpc.v6i6.3320Abstract
Due to the resistance and exertion of severe side effects of current anticancer drugs, development of new anticancer agents is one of the main goals in medicinal chemistry.Apoptosis process is occurred in all organisms to control their cell numbers and to omit extra or damaged cells.Caspases are an enzyme family that precedes apoptosis.Activation of caspases results in irreversible apoptotic cell death. Naphthalimide derivatives as DNA intercalators have exhibited high anticancer activities against various cell lines.Some naphthalimides such as amonafide have demonstrated remarkable potency in clinical trials.In the current work, a new series of naphthalimide-based anticancer agents were synthesized. Then, the cytotoxic was evaluated by MTT assay in vitro . Three cancerous cell lines were utilized namely AGS (human gastric carcinoma), HT29 (colorectal cancer), PC3 (prostate cancer) and the obtained results were compared to the doxorubicin as reference drug. In order to study the structure activity relationships of the target compounds, various substituents such as Cl, F, NO 2 and -OCH 3 were introduced on the phenyl ring. Generally, electron withdrawing substituents caused better anticancer activity compared to doxorubicin. Some selected derivatives activated the caspase 3 more than control drug and also influenced on mitochondrial membrane potential (MMP) and reduced it. It means that these compounds may induce the apoptosis n via the intrinsic pathway. Production of intracellular reactive oxygen species (ROS) was also investigated and the obtained results showed that the most of the tested compounds induced the production of free radicals less than control drug.Downloads
References
References
Levitzki A, Klein S. Signal transduction therapy of cancer. Mol Aspects Med 2010; 31: 287-29.
Kemnitzer W, Kuemmerle J, Jiang S, Zhang HZ, Sirisoma N, Kasibhatla S. et al. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Part 1: Structure-activity relationships of the 1- and 3-positions. Bioorg Med Chem Lett 2008; 18: 6259-64.
Rafael Sierra J, Cepero V, Giordano S. Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy. Mol Cancer 2010; 9: 75-87.
Arora A, Scholar EM. Role of Tyrosine Kinase Inhibitors in Cancer Therapy. J Pharmacol Exp Ther 2005; 3: 971-9.
Sirisoma N, Pervin A, Drewe J, Tseng B, Cai SX. Discovery of substituted N'-(2-oxoindolin-3-ylidene)benzohydrazides as new apoptosis inducers using a cell- and caspase-based HTS assay. Bioorg Med Chem Lett 2009; 19: 2710-13.
Kemnitzer W, Kuemmerle J, Zhang HZ, Kasibhatla S, Tseng B, Drewe J, Cai SX. Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents. Bioorg Med Chem Lett 2009; 15: 4410-15.
Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-24.
Bratton SB, MacFarlane M, Cain K, Cohen GM. Protein complexes activate distinct caspase cascades in death receptor and stress-activated apoptosis. Exp Cell Res 2000; 256: 27-3.
Hirata H, Takahashi A, Kobayashi S, et al. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 1998; 187: 587-00.
Jiang S, Crogan-Grundy C, Drewe J, Tseng B, Cai SX. Discovery of (naphthalen-4-yl)(phenyl)methanones and N-methyl-N-phenylnaphthalen-1-amines as new apoptosis inducers using a cell- and caspase-based HTS assay. Bioorg Med Chem Lett 2008; 18: 5725-28.
Bortner CD, Cidlowski J-A. A necessary role for cell shrinkage in apoptosis. Biochem Pharmacol 1998; 56: 1549-59.
Milelli A, Tumiatti V, Micco M, Rosini M, Zuccari G, Raffaghello L, et al. Structure-activity relationships of novel substituted naphthalene diimides as anticancer agents. Eur J Med Chem 2012; 57: 417-28.
Yang L, Li W, Tian Z, Zhao J, Wang C. Mononaphthalimide spermidine conjugate induces cell proliferation inhibition and apoptosis in HeLa cells. Toxicol in Vitro 2011; 25: 882-89.
Wu A, Xu Y, Qian X. Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: Design, synthesis and potential antitumor activity. Bioorg Med Chem 2009; 17: 592-99.
Aibin W, Yufang X, Xuhong Q, Jin W, Jianwen L. Novel naphthalimide derivatives as potential apoptosis-inducing agents: Design, synthesis and biological evaluation. Eur J Med Chem 2009; 44: 4674-80.
Wang K, Wang Y, Yan X, Chen H, Ma G, Zhang P, et al. DNA binding and anticancer activity of naphthalimides with 4-hydroxyl-alkylamine side chains at different lengths. Bioorg Med Chem Lett 2012; 22: 937-41.
Shenghui L, Shengjie X, Yonghe T, Shan D, Jinchao Zh, Shuxiang W. et al. Synthesis, anticancer activity and DNA-binding properties of novel 4-pyrazolyl-1,8-naphthalimide derivatives. Bioorg Med Chem Lett 2014; 24: 586-90.
Xin W, Zhuo Ch, Linjiang T, Shaoying T, Wei Zh, Ting P. et al. Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs). Eur J Med Chem 2013; 65: 477-86.
Xiaolian L, Yanjie L, Yukun Y, Kai L, Xuhong Q. Novel efficient anticancer agents and DNA-intercalators of 1,2,3-triazol-1,8-naphthalimides: design, synthesis, and biological activity. Tetrahedron 2011; 67: 2299-03.
Ugir Hossain Sk, Prakasha Gowda AS, Melissa A. Crampsie, Jong K. Yun, Thomas E. et al. Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeutics. Eur J Med Chem 2011; 46: 3331-38.
Aliabadi A, Gholamine B, Karimi T. Synthesis and antiseizure evaluation of isoindoline-1,3-dione derivatives in mice. Med Chem Res 2014; 23: 2736-43.
Foroumadi A, Mohammadi-Farani A, Garmsiri Mahvar M, Aliabadi A. Synthesis and evaluation of anti-acetylcholinesterase activity of 2-(2-(4-(2-Oxo-2-phenylethyl)piperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives with potential anti-Alzheimer effects. Iran J Basic Med Sci 2013; 10(16): 1049-54.
Mohammadi-Farani A, Ahmadi A, Nadri H, Aliabadi A. Synthesis, docking and acetylcholinesterase inhibitory assessment of 2-(2-(4-Benzylpiperazin-1-yl)ethyl)isoindoline-1,3-dione with potential anti-alzheimer effects. Daru: J Pharm Sci 2013; 21: 47-55.
Aliabadi A, Mohammadi-Farani A, Hosseinzadeh Z, Nadri H, Moradi A, Ahmadi F. Phthalimide analogs as probable 15-lipoxygenase-1 inhibitors: Synthesis, biological evaluation and docking studies. Daru: J. Pharm. Sci. 2015, 23: 36-43.
Hosseinzadeh L, Khorand A, Aliabadi A. Discovery of 2-Phenyl-N-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)acetamide derivatives as apoptosis inducers via caspases pathway with potential anticancer activity. Arch Pharm Chem 2013; 11 (346): 812-18.
Wang M, Ruan Y, Chen Q, Li S, Wang Q, Cai J. Curcumin induced HepG2 cell apoptosis-associated mitochondrial membrane potential and intracellular free Ca2+ concentration. Eur J Pharmacol 2011; 1: 41-7.
Choi DJ, Kim SL, Choi JW, Park YI. Neuroprotective effects of corn silk maysin via inhibition of H2O2-induced apoptotic cell death in SKNMC cells. Life Sci 2014; 109(1): 57-4.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
- The author must submit Copyright form After acceptance of the article.
How to Cite
